2,571 results on '"Carvalho, S"'
Search Results
302. The role of seagrass vegetation and local environmental conditions in shaping benthic bacterial and macroinvertebrate communities in a tropical coastal lagoon
- Author
-
Alsaffar, Z., primary, Pearman, J. K., additional, Cúrdia, J., additional, Ellis, J., additional, Calleja, M. Ll., additional, Ruiz-Compean, P., additional, Roth, F., additional, Villalobos, R., additional, Jones, B. H., additional, Morán, X. A. G., additional, and Carvalho, S., additional
- Published
- 2020
- Full Text
- View/download PDF
303. The solar photo-Fenton process at neutral pH applied to microcystin-LR degradation: Fe2+, H2O2 and reaction matrix effects
- Author
-
Micheletto, Joicy, primary, de Torres, Mariana Almeida, additional, de Paula, Vinícius de Carvalho S., additional, Cerutti, Vânia Eloiza, additional, Pagioro, Thomaz Aurélio, additional, Cass, Quezia Bezerra, additional, Martins, Lucia Regina R., additional, de Liz, Marcus Vinicius, additional, and de Freitas, Adriane Martins, additional
- Published
- 2020
- Full Text
- View/download PDF
304. Comparison of automatic methods to detect sunspots in the Coimbra Observatory spectroheliograms
- Author
-
Carvalho, S., primary, Gomes, S., additional, Barata, T., additional, Lourenço, A., additional, and Peixinho, N., additional
- Published
- 2020
- Full Text
- View/download PDF
305. Association between functional physical fitness and health status of the elderly
- Author
-
Batista, A, primary, Flores, G, primary, Carvalho, S, primary, Sampaio, M, primary, and Patrício, C, primary
- Published
- 2020
- Full Text
- View/download PDF
306. Development of stacked porous tantalum oxide layers by anodization
- Author
-
Fialho, L., primary, Almeida Alves, C.F., additional, Marques, L.S., additional, and Carvalho, S., additional
- Published
- 2020
- Full Text
- View/download PDF
307. Passivation and dissolution mechanisms in ordered anodic tantalum oxide nanostructures
- Author
-
Almeida Alves, C.F., primary, Calderon V., S., additional, Ferreira, P.J., additional, Marques, L., additional, and Carvalho, S., additional
- Published
- 2020
- Full Text
- View/download PDF
308. Tribological performance of hybrid surfaces: dimple-shaped anodized Al alloy surfaces coated with WS-CF sputtered thin films
- Author
-
Rodrigues, S. P., primary, Carvalho, S., additional, and Cavaleiro, A., additional
- Published
- 2020
- Full Text
- View/download PDF
309. Surface functionalization of 3D printed structures: Aesthetic and antibiofouling properties
- Author
-
Castro, José D., primary, Carneiro, E., additional, Marques, S.M., additional, Figueiredo, Bruno, additional, Pontes, Antonio J., additional, Sampaio, Álvaro M., additional, Carvalho, Isabel, additional, Henriques, Mariana, additional, Cruz, Paulo J.S., additional, and Carvalho, S., additional
- Published
- 2020
- Full Text
- View/download PDF
310. Chemical abundances of Seyfert 2 AGNs – II. N2 metallicity calibration based on SDSS
- Author
-
Carvalho, S P, primary, Dors, O L, additional, Cardaci, M V, additional, Hägele, G F, additional, Krabbe, A C, additional, Pérez-Montero, E, additional, Monteiro, A F, additional, Armah, M, additional, and Freitas-Lemes, P, additional
- Published
- 2020
- Full Text
- View/download PDF
311. Fármacos antidepressivos: prevalência, perfil e conhecimento da população usuária
- Author
-
Cruz, André Fabricio Pereira da, primary, Melho, V. M., additional, Souza, B. F.X. De, additional, Silva, G. R., additional, Silva, P.E. E.M., additional, and Carvalho, S. J., additional
- Published
- 2020
- Full Text
- View/download PDF
312. Prevention strategies in weed management.
- Author
-
Christoffoleti, P. J., primary, Carvalho, S. J. P., additional, Nicolai, M., additional, Doohan, D., additional, and VanGessel, M., additional
- Published
- 2007
- Full Text
- View/download PDF
313. Vestibular evoked myogenic potential findings in multiple sclerosis: P1636
- Author
-
Felipe, L., Kingma, H., Lambertucci, J. R., Carvalho, S. A., Cunha, L. C., Gonçalves, D. U., and Lanna-Peixoto, M. A.
- Published
- 2010
314. Structural stability of decorative ZrNxOy thin films
- Author
-
Carvalho, P., Vaz, F., Rebouta, L., Carvalho, S., Cunha, L., Goudeau, Ph., Rivière, J.P., Alves, E., and Cavaleiro, A.
- Published
- 2005
- Full Text
- View/download PDF
315. Can we infer dredge fishing effort from macrobenthic community structure?
- Author
-
Gaspar, M B, Carvalho, S, Constantino, R, Tata-Regala, J, Cúrdia, J, and Monteiro, C C
- Published
- 2009
316. Higher Gastric IL-10 Levels in H. pylori-Positive Children than Adults may not be Attributed to TregFoxp3 Cells: Abstract no.: W1.2
- Author
-
Queiroz, D. M. M., Rocha, G. A., Melo, F. F., Rocha, A. M. C., Chaves, B. A., Pedroso, S. H. S. P., Castro, L. P. F., Bittencourt, P., Carvalho, S. D., and Corrêa-Oliveira, R.
- Published
- 2009
317. A New Tribometer for the Automotive Industry: Development and Experimental Validation.
- Author
-
Ferreira, R., Carvalho, Ó., Pires, J., Sobral, L., Carvalho, S., and Silva, F.
- Subjects
PISTON rings ,AUTOMOBILE industry ,INTERNAL combustion engines ,AUTOMOTIVE engineering ,SURFACE texture ,DIAMOND-like carbon ,CLINICAL trial registries - Abstract
Background: In automotive engineering, the piston ring-cylinder liner pair is among the most studied contacts. From the three piston rings of a conventional internal combustion engine, the top compression ring has a crucial role. The main challenge is to prevent that during the engine lifecycle, the degradation of the piston ring surface might limit the engine's durability. Objective: However, a reliable evaluation of the piston rings tribological response requires a steady method. To test and study the tribological performance of the ring-liner pair, the development of a customized test rig is presented in this work. Methods: The new oscillating tribometer will test and study the performance of new and commercial piston rings and cylinder liner solutions. According to the foreseen engine operation, four conditions were appointed to perform the control tests, and a testing protocol was established. The selected stainless-steel piston rings were coated with a diamond-like carbon layer, and the cylinder liner parts had the typical plateau honed texture in the contact surface. The friction force measures were recorded. It was also investigated the influence of distinct parameters (such as temperature and contact pressure) in the friction coefficient of this pair. Results: According to the exploratory tests, the major COF was registered for the testing condition with a lower load. In contrast, the lower COF values were recorded for those conditions with superior normal loads and temperatures. Conclusions: The functionality of the developed test rig was verified to evaluate the ring's performance and the liner contact. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
318. Modelling and Performance Evaluation of Wireless Networks
- Author
-
Carvalho, G. H. S., primary, Rodrigues, R. M., additional, Francês, C. R. L., additional, Costa, J. C. W. A., additional, and Carvalho, S. V., additional
- Published
- 2004
- Full Text
- View/download PDF
319. Increase of resistance to glycopeptides and epidemlological changes among nosocomial enterococci detected during 2007 in a Portuguese hospital: O516
- Author
-
Almeida, F., Fernándes, F., Carvalho, S., Ferreira, T., and Mato, R.
- Published
- 2008
320. Raw Material Diversity, Availability and Sourcing in the River Lis Basin, Central Portugal
- Author
-
Pereira, T, Paixão, E, Carvalho, V, Carvalho, S, Gomes, T, Pereira, T, Terradas, X, and Bicho, N
- Abstract
The project EcoPLis - Human Occupations in the Pleistocene Ecotones of the River Lis - started in central Portugal in 2015. It aims to understand the behavioural ecology of hominins during the Pleistocene in a region where sub-rectilinear rivers link the coast to the inland mountains through open riverine and canyon environments. This project is rooted in Leiria’s mapping project - CARQLEI - managed by the City Council that has been mapping archaeological sites and off-sites since 2004, including some identified by Cultural Resource Management projects. One of the most important aims of EcoPLis is the systematic recording and spatial analysis of raw material sources. The Lis basin has a large diversity of rocks suitable for knapping and multiple sources of these materials can be found both in primary and secondary sources. Although rocks are readily available, some materials were selectively sourced and used in the production of stone tools, e.g. chert, quartzite and quartz. The last two are allochthonous, showing great diversity and are highly abundant in river and marine gravels. On the other hand, chert is autochthonous, and it can thus be obtained from secondary and subprimary positions, and extracted from primary outcrops that are considerably limited in space, such as those of the Ribeira das Chitas valley. In this paper we present a tentative map of raw material types and availability in the Lis basin and a preliminary geochemical analysis of chert specimens collected in primary, sub-primary and secondary positions. Our goal is to set a framework for the future investigation of raw material provenance relative to the excavated sites, including a provisional geochemical characterization of the main sources.
- Published
- 2019
321. Tool use and manufacture in the last common ancestor of Pan and Homo
- Author
-
Rolian, C, Carvalho, S, Muller, M, Wrangham, R, and Pilbeam, D
- Published
- 2019
322. Contemporary Presentation and Management of Valvular Heart Disease The EURObservational Research Programme Valvular Heart Disease II Survey
- Author
-
Iung, B., Delgado, V., Rosenhek, R., Price, S., Prendergast, B., Wendler, O., Bonis, M. de, Tribouilloy, C., Evangelista, A., Bogachev-Prokophiev, A., Apor, A., Ince, H., Laroche, C., Popescu, B.A., Pierard, L., Haude, M., Hindricks, G., Ruschitzka, F., Windecker, S., Bax, J.J., Maggioni, A., Vahanian, A., Mekhaldi, S., Lemaitre, K., Authier, S., Druais, H., Goda, A., Mascherbauer, J., Samadov, F., Pasquet, A., Linhartova, K., Ihlemann, N., Abdelhamid, M., Saraste, A., Kostovska, E.S., Bajraktari, G., Mirrakhimov, E., Erglis, A., Mizariene, V., Cassar, D., Tomkiewicz-Pajak, L., Ribeiras, R., Popescu, B., Beleslin, B., Simkova, I., Dogan, S.M., Rahman-Haley, S., Shirka, E., Dado, E., Zera, E., Bica, L., Heger, M., Muslumova, F., Jahangirov, T., Ahmedov, T., Husseynov, S., Cosyns, B., Camp, G. van, Sindelarova, S., Branny, M., Parenicova, I., Vondrackova, D.J., Homza, M., Ostransky, J., Hasan-Ali, H., Abdelhady, Y., Hassan, M., Soliman, H., Mostafa, A.E., Moaaz, M., Kazamel, G., Sadek, Y., Eltobgi, S., Kamal, D., Kylmala, M., Turpeinen, A., Monin, J.L., Jobic, Y., Attias, D., Magne, J., Marechaux, S., Donal, E., Biere, L., Bernard, A., Daudin, M., Khounlaboud, M., Habib, G., Bardet, H., Audonnet, M., Thuny, F., Plurien, F., Berenfeld, A., Gervais, R., Sorbets, E., Charbonnier, A., Bauer, F., Menager-Gangloff, C., Gjerakorska-Radovikj, M., Jordanova, S., Caglayan, E., Hambrecht, R., Akin, I., Maier, L., Nickenig, G., Scholtz, W., Schulze, P.C., Heintzen, M., Er, F., Sigusch, H., Spargias, K., Kamperidis, V., Sachpekidis, V., Bellos, V., Kanakakis, I., Papafaklis, M., Makris, A., Poulimenos, L., Katsaros, A., Lampropoulos, K., Bartha, E., Zsary, A., Jebelovszki, E., Cziraki, A., Borsanyi, T., Lupkovics, G., Jarai, Z., Ibrahimi, P., Arapova, R., Laahunova, E., Sime, I., Rancane, G., Radauskaite, G., Raugaliene, R., Xuereb, R.G., Djaberi, R., Komar, M., Szymanski, P., Zaborska, B., Mizia-Stec, K., Regulski, M., Bogacki, P., Sedziwy, E., Komor, K., Myszor, J., Joao, I., Martins, R., Cabral, S., Gago, P., Cardoso, G., Almeida, I., Antunes, N., Carvalho, S., Galrinho, A., Freitas, A., Grigorica, L., Mitre, A., Ionac, A., Tint, D., Popescu, A., Petris, A.O., Onut, R., Pop, C., Usurelu, C., Beyer, R., Militaru, C., Eminovici, G., Arsenescu-Georgescu, C., Irtyuga, O., Semenova, E., Boldyrev, S., Kozmin, D., Gross, Y., Zotov, A., Kuznetsov, D., Nemchenko, E., Kulumbegov, O., Jakubov, R., Stefanov, S., Schneider, Y., Tsechanovich, V., Gamzaev, A., Fomenko, M., Mayorova, O., Skripkina, E., Safina, V., Slastin, Y., Koroleva, T., Polyaeva, L., Tarasenko, I., Alekseeva, S., Magamet, V., Medvedev, I., Khilova, L., Verevetinov, A., Stojsic-Milosavljevic, A., Nikolic, N.M., Ostric, D.K., Ruzicic, D., Pavlovic, S., Milosavljevic, J., Jovovic, L., Margoczy, R., Valocik, G., Studencan, M., Iglesias, F.C., Mendez, I., Gomez, A.G., Sanchez Fernandez, P.L., Valenzuela, G.M., Cladellas, M., Villegas, D.V., Moral, S., Gallego, I.M., Paya, R., Caballero, L., Paton, R.R., Esteban, E., Iglesia-Carreno, C., Alberca, M.T., Valle, A., Molina-Mora, M.J., Castro, N., Sayar, N., Demirtas, A.O., Yesilay, A., Demir, S., Bozkurt, A., Kanar, B., Gudul, N.E., Yildirim, T., Taylan, G., Mert, K.U., Yilmaztepe, M.A., Mert, G.O., Cosansu, K., Sayin, M.R., Karabag, T., EORP VHD II Investigators, Instituto Universitario de Investigacion de Nanocienca de Aragon, University of Zaragoza - Universidad de Zaragoza [Zaragoza], Instituto de Física de Cantabria (IFCA), Universidad de Cantabria [Santander]-Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Leibniz Institute for Astrophysics Potsdam (AIP), St. Josef Hospital, Ruhr-University Bochum, Université Paris Diderot - Paris 7 (UPD7), Institut National de la Santé et de la Recherche Médicale (INSERM), Leiden University Medical Center (LUMC), Universiteit Leiden, Medizinische Universität Wien = Medical University of Vienna, Department of Imaging Royal Brompton Hospital, Royal Brompton Hospital, Guy's and St Thomas' Hospital [London], CHU Amiens-Picardie, Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517 (MP3CV), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Vall d'Hebron University Hospital [Barcelona], Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Liège (CHU-Liège), Lukaskrankenhaus, Universität Leipzig, University Heart Centre Freiburg - Bad Krozingen, Research Center [Associazione Nazionale Medici Cardiologi Ospedalieri] (ANMCO Research Center), Associazione Nazionale Medici Cardiologi Ospedalieri [Firenze] (ANMCO), Service de cardiologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Uppsala University, SAFRAN Group, Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (VUB), Université de Lille, Sciences et Technologies, Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes - Faculté de Médecine (UR Médecine), Université de Rennes (UR), CHU Pontchaillou [Rennes], Laboratoire de Protection et Remodelage du Myocarde (PMRM), Université d'Angers (UA)-Université d'Angers (UA), Laboratoire d'Excellence : Lipoprotéines et Santé : prévention et Traitement des maladies Inflammatoires et du Cancer (LabEx LipSTIC), Institut National de la Recherche Agronomique (INRA)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université Paris-Sud - Paris 11 (UP11)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut Gustave Roussy (IGR)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Bourgogne (UB)-Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM)-Fédération Francophone de la Cancérologie Digestive, FFCD-Université de Montpellier (UM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), CHU de Saint-Brieuc, Hôpital Lapeyronie [Montpellier] (CHU), Assistance Publique - Hôpitaux de Marseille (APHM), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut de la Vision, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, University of Latvia (LU), Dipartimento di Scienza dei Materiali = Department of Materials Science [Milano-Bicocca], Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), MDM Laboratory, IMM-CNR, Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Réseaux épuration et qualité des eaux (UR REBX), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), King Abdullah University of Science and Technology (KAUST), INSTITUTO NACIONAL DE INVESTIGACAO AGRARIA E VETERINARIA VILA DO CONDE PRT, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Université de Médecine Carol Davila, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C.C. Iliescu' [Bucharest, Romania], Département Intelligence Ambiante et Systèmes Interactifs (DIASI), Laboratoire d'Intégration des Systèmes et des Technologies (LIST (CEA)), Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of photonics engineering, Danmarks Tekniske Universitet = Technical University of Denmark (DTU), Clinical sciences, Cardio-vascular diseases, Cardiology, Universität Leipzig [Leipzig], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes 1 - Faculté de Médecine (UR1 Médecine), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Institut National de la Recherche Agronomique (INRA)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université Paris-Sud - Paris 11 (UP11)-École pratique des hautes études (EPHE), UNICANCER-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM)-Fédération Francophone de la Cancérologie Digestive, FFCD-Université de Montpellier (UM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Università degli Studi di Milano-Bicocca [Milano] (UNIMIB), Technical University of Denmark [Lyngby] (DTU), Université d'Angers (UA), Iung, Bernard, Delgado, Victoria, Rosenhek, Raphael, Price, Susanna, Prendergast, Bernard, Wendler, Olaf, De Bonis, Michele, Tribouilloy, Christophe, Evangelista, Arturo, Bogachev-Prokophiev, Alexander, Apor, Astrid, Ince, Hüseyin, Laroche, Cécile, Popescu, Bogdan A, Piérard, Luc, Haude, Michael, Hindricks, Gerhard, Ruschitzka, Frank, Windecker, Stephan, Bax, Jeroen J, Maggioni, Aldo, and Vahanian, Alec
- Subjects
Male ,Time Factors ,[SDV]Life Sciences [q-bio] ,030204 cardiovascular system & hematology ,heart valve diseases ,valvular surgery ,Cardiologists ,0302 clinical medicine ,Time-to-Treatment/trends ,Referral and Consultation/trends ,Heart Valve Diseases/diagnosis ,Medicine ,echocardiography ,03.02. Klinikai orvostan ,030212 general & internal medicine ,Prospective Studies ,Practice Patterns, Physicians' ,610 Medicine & health ,Referral and Consultation ,valvular heart disease ,Middle Aged ,Europe ,Practice Guidelines as Topic ,cardiovascular system ,Healthcare Disparities/trends ,transcatheter aortic valve replacement ,Female ,Guideline Adherence ,Presentation (obstetrics) ,Cardiology and Cardiovascular Medicine ,guideline ,Cardiologists/trends ,medicine.medical_specialty ,transcatheter intervention ,Clinical Decision-Making ,Time-to-Treatment ,Europe/epidemiology ,03 medical and health sciences ,Physiology (medical) ,Guideline Adherence/trends ,Humans ,Healthcare Disparities ,Intensive care medicine ,Aged ,business.industry ,medicine.disease ,Practice Patterns, Physicians'/trends ,Health Care Surveys ,business ,aged, 80 and over ,guidelines as topic - Abstract
Background: Valvular heart disease (VHD) is an important cause of mortality and morbidity and has been subject to important changes in management. The VHD II survey was designed by the EURObservational Research Programme of the European Society of Cardiology to analyze actual management of VHD and to compare practice with guidelines. Methods: Patients with severe native VHD or previous valvular intervention were enrolled prospectively across 28 countries over a 3-month period in 2017. Indications for intervention were considered concordant if the intervention was performed or scheduled in symptomatic patients, corresponding to Class I recommendations specified in the 2012 European Society of Cardiology and in the 2014 American Heart Association/American College of Cardiology VHD guidelines. Results: A total of 7247 patients (4483 hospitalized, 2764 outpatients) were included in 222 centers. Median age was 71 years (interquartile range, 62–80 years); 1917 patients (26.5%) were ≥80 years; and 3416 were female (47.1%). Severe native VHD was present in 5219 patients (72.0%): aortic stenosis in 2152 (41.2% of native VHD), aortic regurgitation in 279 (5.3%), mitral stenosis in 234 (4.5%), mitral regurgitation in 1114 (21.3%; primary in 746 and secondary in 368), multiple left-sided VHD in 1297 (24.9%), and right-sided VHD in 143 (2.7%). Two thousand twenty-eight patients (28.0%) had undergone previous valvular intervention. Intervention was performed in 37.0% and scheduled in 26.8% of patients with native VHD. The decision for intervention was concordant with Class I recommendations in symptomatic patients with severe single left-sided native VHD in 79.4% (95% CI, 77.1–81.6) for aortic stenosis, 77.6% (95% CI, 69.9–84.0) for aortic regurgitation, 68.5% (95% CI, 60.8–75.4) for mitral stenosis, and 71.0% (95% CI, 66.4–75.3) for primary mitral regurgitation. Valvular interventions were performed in 2150 patients during the survey; of them, 47.8% of patients with single left-sided native VHD were in New York Heart Association class III or IV. Transcatheter procedures were performed in 38.7% of patients with aortic stenosis and 16.7% of those with mitral regurgitation. Conclusions: Despite good concordance between Class I recommendations and practice in patients with aortic VHD, the suboptimal number in mitral VHD and late referral for valvular interventions suggest the need to improve further guideline implementation.
- Published
- 2019
- Full Text
- View/download PDF
323. (CHAR)LAR: UMA EXPERIMENTA����O DE GERA����O DE POEMAS BASEADA EM REDES NEURAIS RECORRENTES
- Author
-
Oliveira, Luma Wanderley de, Nascimento, Hugo Alexandre Dantas do, and Carvalho, S��rgio Teixeira de
- Abstract
The scientific advances in the research on artificial neural networks have raised the computer's generative potential, with interesting developments in the computational art. Projects in this direction include the development of an artificial neural network that learns an artist's painting style and applies it to other images, as well as the Google Brain project, which investigates the use of neural networks for the automatic production of songs and texts. In the present work, we describe an experiment carried out with the aim of creating poems in an autonomous way. The approach consisted in adopting a recurrent neural network of the LSTM type and training it on a body of poems in the Portuguese language from the 16th to the 20th centuries, involving 604 thousand characters. The trained network is able to generate new poems in the learned style and is undergoing an evaluation process. Os avan��os cient��ficos na pesquisa sobre redes neurais artificiais t��m elevado o potencial gerativo do computador, com interessantes desdobramentos na ��rea de arte computacional. Projetos nesse sentido incluem o desenvolvimento de uma rede neural artificial que aprende o estilo de pintura de um artista e o aplica a outras imagens, bem como o projeto Google Brain, o qual investiga a utiliza����o de redes neurais para a produ����o autom��tica de m��sicas e de textos. No presente trabalho, descrevemos um experimento realizado com o objetivo de criar poemas de maneira aut��noma. A abordagem consistiu em adotar uma rede neural recorrente do tipo LSTM e trein��-la sobre um corpo de poemas na l��ngua portuguesa dos s��culos XVI ao XX, envolvendo mais de um milh��o de caracteres. A rede treinada consegue gerar novos poemas no estilo aprendido e est�� passando por um processo de avalia����o.
- Published
- 2019
- Full Text
- View/download PDF
324. Primate Archaeology
- Author
-
Ribeiro Marques De Carvalho, S and Almeida-Warren, K
- Published
- 2019
325. Modulação neuro-hormonal
- Author
-
Silva-Cardoso, J., Brás, D., Canário-Almeida, F., Andrade, A., Oliveira, L., Pádua, F., Fonseca, C., Bragança, N., Carvalho, S., Soares, R., Santos, J. Ferreira, and NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
- Subjects
Cardiovascular mortality ,Hospitalization due to heart failure ,PARADIGM-HF ,Angiotensin-receptor neprilysin inhibitor ,Sacubitril/valsartan ,Neurohormonal modulation ,Heart failure with reduced ejection fraction ,Cardiology and Cardiovascular Medicine - Abstract
The current paradigm of medical therapy for heart failure with reduced ejection fraction (HFrEF) is triple neurohormonal blockade with an angiotensin-converting enzyme inhibitor (ACEI), a beta-blocker (BB) and a mineralocorticoid receptor antagonist (MRA). However, three-year mortality remains over 30%. Stimulation of counter-regulatory systems in addition to neurohormonal blockade constitutes a new paradigm, termed neurohormonal modulation. Sacubitril/valsartan is the first element of this new strategy. PARADIGM-HF was the largest randomized clinical trial conducted in HFrEF. It included 8442 patients and compared the efficacy and safety of sacubitril/valsartan versus enalapril. The primary endpoint was the composite of cardiovascular mortality and hospitalization due to HF, which occurred in 914 (21.8%) patients receiving sacubitril/valsartan and in 1117 (26.5%) patients receiving enalapril (HR 0.8, 95% CI 0.73-0.87, p=0.0000002; NNT 21). Sacubitril/valsartan reduced both primary endpoint components, as well as sudden cardiac death, death due to worsening HF, and death from all causes. Patients on sacubitril/valsartan reported less frequent deterioration of HF and of quality of life, and discontinued study medication less frequently because of an adverse event. PARADIGM-HF demonstrated the superiority of sacubitril/valsartan over enalapril, with a 20% greater impact on cardiovascular mortality compared to ACEIs. Accordingly, in 2016, the European (ESC) and American (ACC/AHA/HFSA) cardiology societies simultaneously issued a class I recommendation for the replacement of ACEIs by sacubitril/valsartan in patients resembling PARADIGM-HF trial participants. publishersversion published
- Published
- 2019
326. COMPLEXOS de Inclusão Furazolidona:ciclodextrinas Visando o Desenvolvimento de Medicamentos para o Tratamento da Leishmaniose Cutânea Canina: Caracterização Física e Avaliação Biológica In Vitro
- Author
-
CARVALHO, S. G., GIUBERTI, C. S., SEVERI, J. A., KONISHI, J. C. O. V., and FREITAS, J. C. C.
- Subjects
hidroxipropil-946 ,ciclodextrina - Abstract
Made available in DSpace on 2019-03-11T12:47:07Z (GMT). No. of bitstreams: 1 tese_12292_SUZANA GONÇALVES CARVALHO20190308-111655.pdf: 2328807 bytes, checksum: 12046af4b7f90073c7e295cdc878d9ab (MD5) Previous issue date: 2019-02-18 A leishmaniose cutânea é uma doença zoonose, sendo causada por protozoários do gênero Leishmania. A leishmaniose cutânea canina (LCC) é considerada uma antropozoonose e, atualmente não existe farmacoterapia disponível, no Brasil, para o seu tratamento. Assim, a busca por alternativas farmacêuticas para uso nos animais tem sido objeto de inúmeras pesquisas. Neste cenário, a atividade leishmanicida da furazolidona vem sendo estudada por diversos pesquisadores e, uma vez que o fármaco não é utilizado no tratamento das leishmanioses no homem, seu uso para o tratamento da LCC pode ser considerado. Relatos ciêntíficos apontam a furazolidona como um quimioterápico com boa atividade leishmanicida. Contudo, problemas de toxicidade animal também são relatados, o que pode estar relacionado a sua baixa solubilidade e altas doses requeridas para que o efeito terapêutico seja alcançado. Entre as inúmeras alternativas farmacotécnicas disponíveis para contornar problemas de solubilidade, a formação de complexos de inclusão com ciclodextrinas merece destaque. Além de melhorar a solubilidade e a biodisponibilidade das moléculas hóspedes, a formação de complexos de inclusão (CIs) pode aumentar a estabilidade e favorecer o mascaramento do sabor dos fármacos. Neste contexto, o objetivo do presente estudo foi preparar CIs entre a furazolidona (FZD) e duas ciclodextrinas de interesse farmacêutico: a β-ciclodextrina (βCD) e a hidroxi-propil-β-ciclodextrina (HPβCD). Os CIs foram preparados nas razões molares 1:1 e 1:2 (FZD:CD) pelos métodos de malaxagem e liofilização. A presença de amorfização das partículas e o sucesso da complexação foram confirmadas empregando técnicas de caracterização física e química, a saber: calorimetria exploratória diferencial (DSC), termogravimetria (TG/DTG), microscopia eletrônica de varredura (MEV), difração de raios X (DRX), espectroscopia Raman e ressonância magnética nuclear (RMN) de 13C no estado sólido. Após a caracterização físico-química, avaliou-se a atividade leishmanicida 7 utilizando o método calorimétrico de redução da resazurina em formas promastigotas. A citotoxicidade foi avaliada sobre macrófagos provenientes de monócitos THP-1, empregando-se o ensaio calorimétrico com MTT. Os processos de malaxagem e liofilização escolhidos para a obtenção dos complexos, se mostraram simples e de fácil execução, passíveis de serem escalonadas. A presença de amorfização e a indicação de complexação para os produtos obtidos a partir da β-CD e da HP-β-CD, na razão molar 1:2, preparadas por liofilização, foi confirmada por todas as técnicas utilizadas. Em todos os demais produtos, foi constatada a ocorrência de interações entre o fármaco e as ciclodextrinas em estudo, indicando a formação de agregados do tipo não-complexo. Todas as amostras apresentaram atividade leishmanicida e se mostraram não tóxicas para macrófagos THP-1. Os valores do IC50 para os produtos de complexação MHFZD1:2 e LHFZD1:2 foram 2,7 e 3,02 µg/mL, respectivamente, sendo ambos considerados promissores para o desenvolvimento de medicamentos de uso veterinário com vistas ao uso no tratamento de leismanioses em cães.
- Published
- 2019
327. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery
- Author
-
Howell, SJ, Hoeks, SE, West, RM, Wheatcroft, SB, Hoeft, A, OBTAIN Investigators of European Society of Anaesthesiology (ESA, Leva, B, Plichon, B, Damster, S, Momeni, M, Watremez, C, Kahn, D, Dincq, A-S, Danila, A, Wittmann, M, Struck, R, Rüddel, T, Kessler, F, Rasche, S, Matsota, P, Hasani, A, Gudaityte, J, Karbonskiene, A, Ferreira, R, Carvalho, S, Tomescu, D, Martac, C, Grintescu, I, Mirea, L, Serrano, L, Sierra, P, Sabaté, S, Hernando, D, Matute, P, Trashorras, M, Suñé, M, Sarmiento, L, Hervias, A, González, O, Hermina, A, Navarro Perez, R, Orts, M, Fernandez-Garcia, R, Sanchez Pérez, D, Sepulveda Gil, I, Monedero, P, Hidalgo, F, Mbongo, C, Pont, AR, Reyes, HM, Bartolo, CG, Galera, SL, Valentijn, T, Stolker, RJ, Tugrul, M, Demirel, EE, Hough, M, Griffiths, K, Birch, S, Beardow, Z, Elliot, S, Thompson, J, Bowrey, S, Northey, M, Melson, H, Telford, R, Nadolski, M, Potter, A, Fuller, D, Rose, A, Varma, S, Simeson, K, Pettit, J, Smith, N, Martinson, V, Sleight, L, Naylor, C, Watt, P, Raymode, P, Dunk, N, Twohey, L, Hollos, L, Davies, S, Gibson, A, Coleman, Z, Tamm, T, Joscak, J, Zsisku, L, Zuleika, M, Carvalho, P, Collyer, T, Ryan, J, Colling, K, Dharmarajah, S, Krishnan, A, Paddle, J, Fouracres, A, Arnell, K, and Muhammad, K
- Subjects
animal structures ,cardiovascular diseases - Abstract
Background: The perioperative management of antiplatelet therapy in noncardiac surgery patients who have undergone previous percutaneous coronary intervention (PCI) remains a dilemma. Continuing dual antiplatelet therapy (DAPT) may carry a risk of bleeding, while stopping antiplatelet therapy may increase the risk of perioperative major adverse cardiovascular events (MACE). Methods: Occurrence of Bleeding and Thrombosis during Antiplatelet Therapy In Non-Cardiac Surgery (OBTAIN) was an international prospective multicentre cohort study of perioperative antiplatelet treatment, MACE, and serious bleeding in noncardiac surgery. The incidences of MACE and bleeding were compared in patients receiving DAPT, monotherapy, and no antiplatelet therapy before surgery. Unadjusted risk ratios were calculated taking monotherapy as the baseline. The adjusted risks of bleeding and MACE were compared in patients receiving monotherapy and DAPT using propensity score matching. Results: A total of 917 patients were recruited and 847 were eligible for inclusion. Ninety-six patients received no antiplatelet therapy, 526 received monotherapy with aspirin, and 225 received DAPT. Thirty-two patients suffered MACE and 22 had bleeding. The unadjusted risk ratio for MACE in patients receiving DAPT compared with monotherapy was 1.9 (0.93–3.88), P=0.08. There was no difference in MACE between no antiplatelet treatment and monotherapy 1.03 (0.31–3.46), P=0.96. Bleeding was more frequent with DAPT 6.55 (2.3–17.96) P=0.0002. In a propensity matched analysis of 177 patients who received DAPT and 177 monotherapy patients, the risk ratio for MACE with DAPT was 1.83 (0.69–4.85), P=0.32. The risk of bleeding was significantly greater in the DAPT group 4.00 (1.15–13.93), P=0.031. Conclusions: OBTAIN showed an increased risk of bleeding with DAPT and found no evidence for protective effects of DAPT from perioperative MACE in patients who have undergone previous PCI.
- Published
- 2019
328. Genetic diversity of a native population of Myrcia ovata (Myrtaceae) using ISSR molecular markers
- Author
-
WHITE, L. A. S., MUNIZ, A. V. C. da S., ALVARES CARVALHO, S. V., SILVA MANN, R., ARRIGONI BLANK, M. F., SOUZA, E. M. S., ALMEIDA, C. S., NIZIO, D. A. C., SAMPAIO, T. S., BLANK, A. F., ANA VERUSKA CRUZ DA SILVA MUNIZ, CPATC, and S.V. Alvares-Carvalho.
- Subjects
Medicinal plants ,Planta Medicinal - Abstract
Made available in DSpace on 2020-01-14T18:13:19Z (GMT). No. of bitstreams: 1 gmr18022geneticdiversitynativepopulation.pdf: 694093 bytes, checksum: 73dd25b4adfd325840e37aa0db62c48b (MD5) Previous issue date: 2019
- Published
- 2019
329. A importância dos recursos genéticos vegetais para a olericultura brasileira
- Author
-
CARVALHO, S. I. C. de, AMARO, G. B., SABRINA ISABEL COSTA DE CARVALHO, CNPH, and GEOVANI BERNARDO AMARO, CNPH.
- Subjects
Recurso Genético ,Variedade ,Horticultura - Abstract
Os recursos genéticos vegetais são definidos como parte essencial da biodiversidade, constituídos pela variabilidade genética presente em espécies de plantas de uso atual ou potencial em programas de melhoramento genético, biotecnologia e áreas afins.
- Published
- 2019
330. Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
- Author
-
Chahine, LM, Siderowf, A, Barnes, J, Seedorff, N, Caspell-Garcia, C, Simuni, T, Coffey, CS, Galasko, D, Mollenhauer, B, Arnedo, V, Daegele, N, Frasier, M, Tanner, C, Kieburtz, K, Marek, K, Seibyl, J, Coffey, C, Tosun-Turgut, D, Shaw, L, Trojanowski, J, Singleton, A, Toga, A, Chahine, L, Poewe, W, Foroud, T, Poston, K, Sherer, T, Chowdhury, S, Kopil, C, Casaceli, C, Dorsey, R, Wilson, R, Mahes, S, Salerno, C, Crawford, K, Casalin, P, Malferrari, G, Weisz, MG, Orr-Urtreger, A, Montine, T, Russell, D, Dahodwala, N, Giladi, N, Factor, S, Hogarth, P, Standaert, D, Hauser, R, Jankovic, J, Saint-Hilaire, M, Richard, I, Shprecher, D, Fernandez, H, Brockmann, K, Rosenthal, L, Barone, P, Espay, A, Rowe, D, Marder, K, Santiago, A, Bressman, S, Hu, S-C, Isaacson, S, Corvol, J-C, Ruiz Martinez, J, Tolosa, E, Tai, Y, Politis, M, Smejdir, D, Rees, L, Williams, K, Kausar, F, Richardson, W, Willeke, D, Peacock, S, Sommerfeld, B, Freed, A, Wakeman, K, Blair, C, Guthrie, S, Harrell, L, Hunter, C, Thomas, C-A, James, R, Zimmerman, G, Brown, V, Mule, J, Hilt, E, Ribb, K, Ainscough, S, Wethington, M, Ranola, M, Santana, HM, Moreno, J, Raymond, D, Speketer, K, Carvajal, L, Carvalho, S, Croitoru, I, Garrido, A, Payne, LM, Viswanth, V, Severt, L, Facheris, M, Soares, H, Mintun, MA, Cedarbaum, J, Taylor, P, Biglan, K, Vandenbroucke, E, Sheikh, ZH, Bingol, B, Fischer, T, Sardi, P, Forrat, R, Reith, A, Egebjerg, J, Hillert, GA, Saba, B, Min, C, Umek, R, Mather, J, De Santi, S, Post, A, Boess, F, Taylor, K, Grachev, I, Avbersek, A, Muglia, P, Merchant, K, Tauscher, J, and Michael J Fox Foundation
- Subjects
Male ,Research Report ,0301 basic medicine ,Movement disorders ,Parkinson's disease ,MOTOR PROGRESSION ,Disease ,0601 Biochemistry and Cell Biology ,Severity of Illness Index ,Behavior disorder ,PROGNOSTIC-FACTORS ,0302 clinical medicine ,BOOTSTRAP ,Medicine ,Parkinson’s disease ,biomarkers ,disease progression ,surrogate endpoint ,Prospective Studies ,RATING-SCALE ,Brain ,Parkinson Disease ,Middle Aged ,SPECT ,Female ,medicine.symptom ,Life Sciences & Biomedicine ,medicine.medical_specialty ,Disease duration ,Rapid eye movement sleep ,The Parkinson’s Progression Markers Initiative ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Rating scale ,Internal medicine ,Humans ,Aged ,Dopamine Plasma Membrane Transport Proteins ,Science & Technology ,IDENTIFICATION ,business.industry ,Surrogate endpoint ,Neurosciences ,medicine.disease ,030104 developmental biology ,SLEEP BEHAVIOR DISORDER ,Neurosciences & Neurology ,Neurology (clinical) ,sense organs ,TAU ,1109 Neurosciences ,business ,030217 neurology & neurosurgery - Abstract
Author(s): Chahine, Lana M; Siderowf, Andrew; Barnes, Janel; Seedorff, Nicholas; Caspell-Garcia, Chelsea; Simuni, Tanya; Coffey, Christopher S; Galasko, Douglas; Mollenhauer, Brit; Arnedo, Vanessa; Daegele, Nichole; Frasier, Mark; Tanner, Caroline; Kieburtz, Karl; Marek, Kenneth; The Parkinson’s Progression Markers Initiative | Abstract: BackgroundImproved prediction of Parkinson's disease (PD) progression is needed to support clinical decision-making and to accelerate research trials.ObjectivesTo examine whether baseline measures and their 1-year change predict longer-term progression in early PD.MethodsParkinson's Progression Markers Initiative study data were used. Participants had disease duration ≤2 years, abnormal dopamine transporter (DAT) imaging, and were untreated with PD medications. Baseline and 1-year change in clinical, cerebrospinal fluid (CSF), and imaging measures were evaluated as candidate predictors of longer-term (up to 5 years) change in Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) score and DAT specific binding ratios (SBR) using linear mixed-effects models.ResultsAmong 413 PD participants, median follow-up was 5 years. Change in MDS-UPDRS from year-2 to last follow-up was associated with disease duration (β= 0.351; 95% CI = 0.146, 0.555), male gender (β= 3.090; 95% CI = 0.310, 5.869), and baseline (β= -0.199; 95% CI = -0.315, -0.082) and 1-year change (β= 0.540; 95% CI = 0.423, 0.658) in MDS-UPDRS; predictors in the model accounted for 17.6% of the variance in outcome. Predictors of percent change in mean SBR from year-2 to last follow-up included baseline rapid eye movement sleep behavior disorder score (β= -0.6229; 95% CI = -1.2910, 0.0452), baseline (β= 7.232; 95% CI = 2.268, 12.195) and 1-year change (β= 45.918; 95% CI = 35.994,55.843) in mean striatum SBR, and 1-year change in autonomic symptom score (β= -0.325;95% CI = -0.695, 0.045); predictors in the model accounted for 44.1% of the variance.ConclusionsBaseline clinical, CSF, and imaging measures in early PD predicted change in MDS-UPDRS and dopamine-transporter binding, but the predictive value of the models was low. Adding the short-term change of possible predictors improved the predictive value, especially for modeling change in dopamine-transporter binding.
- Published
- 2019
331. Phage Display combined with Supramolecular Ligand Display enables selection for phosphate-binding motifs
- Author
-
Pina, AS, Morgado, L, Duncan, KL, Carvalho, S, Carvalho, HF, Kalafatović, D, Roque, ACA, and Ulijn, R V
- Subjects
inorganic chemicals ,viruses ,biological sciences ,technology, industry, and agriculture ,Phage Display, phosphate-binding motifs ,macromolecular substances - Abstract
Phage Display combined with Supramolecular Ligand Display enables selection for phosphate-binding motifs
- Published
- 2019
332. Advances in citrus propagation in Brazil
- Author
-
CARVALHO, S. A. de, GIRARDI, E. A., MOURÃO FILHO, F. de A., FERRAREZI, R. S., COLETTA FILHO, H. D., SÉRGIO ALVES DE CARVALHO, EDUARDO AUGUSTO GIRARDI, CNPMF, FRANCISCO DE ASSIS ALVES MOURÃO FILHO, RHUANITO SORANZ FERRAREZI, and HELVÉCIO DELLA COLETTA FILHO.
- Subjects
Fruta Cítrica - Abstract
Made available in DSpace on 2019-12-07T00:38:19Z (GMT). No. of bitstreams: 1 Advances.pdf: 1634397 bytes, checksum: f0f838c56647d56690d89bb526cbf629 (MD5) Previous issue date: 2019
- Published
- 2019
333. Genetic divergence in basil cultivars and hybrids
- Author
-
ALVES, R. P., MUNIZ, A. V. C. da S., PEREIRA, C. S. A., COSTA, T. S., CARVALHO, S. V. A., BLANK, M. de F. A., BLANK, A. F., RODRIGO P. ALVES, ANA VERUSKA CRUZ DA SILVA MUNIZ, CPATC, CAMILA S. ALMEIDA PEREIRA, TATIANA S. COSTA, SHEILA V. ALVARES CARVALHO, MARIA DE FATIMA ARRIGONI BLANK, and ARIE F. BLANK.
- Subjects
Conservação ,Manjericão ,Erva aromática - Abstract
Basil is an aromatic herb that stands out fo its economic importance. It is consumed in natura and sed to obtain essential oil. The cultivation of this species in several regions of the world has allowed variations by natural crosses and euploidy, leading to the wide genetic variability found nowadays. Considering the importance of this species, we aimed to analyze the genetic diversity of 27 basil genotypes using ISSR molecular markers. Fourteen primers were employed for DNA amplification, resulting in 86% polymorphism. Based on the Jaccard?s dissimilarity index, the highest index (0.80) was observed between the individuals BAS001 and BAS012, while the lowest index (0.18) was detected between the genotypes BAS014 and BAS015. The genetic similarity among individuals was calculated, forming four distinct clusters. Most individuals (40.7%) were allocated in cluster I. The polymorphic information content (PIC) (0.89) indicated considerable levels of genetic diversity among genotypes. In this sense, the ISSR markers were efficient in the detection of polymorphisms between the accessions, suggesting the genetic variability of the collection. This result demonstrates the importance of the use of molecular markers and the advantages that this information provides to the breeding of the species. O manjericão é uma erva aromática que se destaca por possuir importância econômica. É consumido in natura e também utilizado na obtenção de óleo essencial. O cultivo desta espécie em diversas regiões do mundo permitiu que surgissem variações mediante cru-zamentos naturais e euploidia, ocasionando a ampla variabilidade genética existente. Considerando a importância desta espécie, este trabalho teve como objetivo analisar a diversidade genética de 27 genótipos de manjericão usando marcadores moleculares ISSR. Qua-torze primers foram utilizados para amplificação do DNA, resultando em 86% de polimorfismo. Com base no índice de dissimilaridade de Jaccard, observou-se o maior índice (0,80) entre os indivíduos BAS001 e BAS012, enquanto que o menor índice de dissimilari-dade (0,18) foi detectado entre os genótipos BAS014 e BAS015. A semelhança genética entre indivíduos foi calculada, formando quatro grupos distintos. A maioria dos indivíduos (40,7%) foi agrupada no grupo I. O conteúdo de informação polimórfica (PIC) (0,89) indicou níveis consideráveis de diversidade genética entre os genótipos. Neste sentido, os marcadores ISSR foram eficientes na detecção de polimorfismos entre os acessos e confirmaram que é possível inferir a variabilidade genética na coleção. Isso demonstra a importância do uso de marcadores moleculares e as vantagens que esta informação pode oferecer ao melhoramento genético das espécies. Made available in DSpace on 2020-01-14T18:11:51Z (GMT). No. of bitstreams: 1 18069991hb3702180.pdf: 930033 bytes, checksum: 67f007a25226e9386cfea7bf3789e54d (MD5) Previous issue date: 2019
- Published
- 2019
334. Reaction of advanced inbred lines of Habanero pepper to Ralstonia pseudosolanacearum and Phytophthora capsici
- Author
-
SOARES, R. S., RIBEIRO, C. S. da C., RAGASSI, C. F., LOPES, C. A., CARVALHO, S. I. C. de, REIS, A., BRAZ, L. T., REIFSCHNEIDER, F. J. B., RENATO S. SOARES, UNIVERSIDADE ESTADUAL PAULISTA, CLAUDIA SILVA DA COSTA RIBEIRO, CNPH, CARLOS FRANCISCO RAGASSI, CNPH, CARLOS ALBERTO LOPES, CNPH, SABRINA ISABEL COSTA DE CARVALHO, CNPH, AILTON REIS, CNPH, LEILA T. BRAZ, UNIVERSIDADE ESTADUAL PAULISTA, and FRANCISCO JOSE BECKER REIFSCHNEIDER, SIRE.
- Subjects
Variedade Resistente ,Murcha de fitoftora ,Capsicum sp ,Murcha Bacteriana - Abstract
The aim of this study was to evaluate the reaction of Habanero-type advanced inbred lines, developed by Embrapa Hortaliças breeding program, to RP and PC. Made available in DSpace on 2019-12-06T00:36:27Z (GMT). No. of bitstreams: 1 20193746.pdf: 1691906 bytes, checksum: 3905f1893691395212eb1a077c8617f2 (MD5) Previous issue date: 2019
- Published
- 2019
335. Serological Blood Screening for Chagasʼ Disease in Brazil: The Contribution of National External QA Program (NEQAP) in Brazilian Blood Banks: A22–020D
- Author
-
Costa, C S, Spindel, R, Lopes, D L, Lameiras, A S, Ferreira, A G, Nóbrega, A K, Bazzo, M L, Carvalho, S M, Gonçales, N S, and Luquetti, A O
- Published
- 2007
336. Effect of depth and reef structure on early macrobenthic communities of the Algarve artificial reefs (southern Portugal)
- Author
-
Moura, A., Boaventura, D., Cúrdia, J., Carvalho, S., da Fonseca, Cancela L., Leitão, F. M., Santos, M. N., and Monteiro, C. C.
- Published
- 2007
- Full Text
- View/download PDF
337. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-γ and interleukin-10 and low frequency of tumour necrosis factor-α+ monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection
- Author
-
Peruhype-Magalhães, V., Martins-Filho, O. A., Prata, A., De A. Silva, L., Rabello, A., Teixeira-Carvalho, A., Figueiredo, R. M., Guimarães-Carvalho, S. F., Ferrari, T. C. A., Van Weyenbergh, J., and Correa-Oliveira, R.
- Published
- 2006
338. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
- Author
-
Reis Filho, J S, Pinheiro, C, Lambros, MBK, Milanezi, F, Carvalho, S, Savage, K, Simpson, P T, Jones, C, Swift, S, Mackay, A, Reis, R M, Hornick, J L, Pereira, E M, Baltazar, F, Fletcher, CDM, Ashworth, A, Lakhani, S R, and Schmitt, F C
- Published
- 2006
339. HSD93 Investigating the Impact of COVID-19 on Haemodialysis
- Author
-
Rice, CT, Unal, GA, João Carvalho, S, and Davidson, J
- Published
- 2022
- Full Text
- View/download PDF
340. Influence of dietary Lupinus luteus , Vicia sativa and Lathyrus cicera on immune response and pancreatic digestive enzymes of early-weaned pigs.
- Author
-
Seabra, M. A., primary, Carvalho, S. M., additional, Freire, J. P. B., additional, Ferreira, R. B., additional, Cunha, L. F., additional, Teixeira, A. R., additional, and Aumaître, A., additional
- Published
- 2001
- Full Text
- View/download PDF
341. Immune Response in Human Visceral Leishmaniasis: Analysis of the Correlation Between Innate Immunity Cytokine Profile and Disease Outcome
- Author
-
Peruhype-Magalhães, V., Martins-Filho, O. A., Prata, A., de A. Silva, L., Rabello, A., Teixeira-Carvalho, A., Figueiredo, R. M., Guimarães-Carvalho, S. F., Ferrari, T. C. A., and Correa-Oliveira, R.
- Published
- 2005
342. Microstructure of (Ti,Si,Al)N nanocomposite coatings
- Author
-
Carvalho, S, Rebouta, L, Ribeiro, E, Vaz, F, Denannot, M.F, Pacaud, J, Rivière, J.P, Paumier, F, Gaboriaud, R.J, and Alves, E
- Published
- 2004
- Full Text
- View/download PDF
343. Microstructure, mechanical properties and cutting performance of superhard (Ti,Si,Al)N nanocomposite films grown by d.c. reactive magnetron sputtering
- Author
-
Carvalho, S, Ribeiro, E, Rebouta, L, Tavares, C, Mendonça, J.P, Caetano Monteiro, A, Carvalho, N.J.M, De Hosson, J.Th.M, and Cavaleiro, A
- Published
- 2004
- Full Text
- View/download PDF
344. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery
- Author
-
Howell, S.J. (Simon), Hoeks, S.E. (Sanne), West, R.M. (Robert), Wheatcroft, T.B. (Tephen), Hoeft, A., Leva, B., Plichon, B., Damster, S., Momeni, M. (Mona), Watremez, C., Kahn, D., Dincq, A.S., Danila, A., Wittmann, M., Struck, R., Ruddel, T., Kessler, F., Rasche, S., Matsota, P., Hasani, A., Gudaityte, J., Karbonskiene, A., Ferreira, R., Carvalho, S., Tomescu, D., Martac, C., Grintescu, I., Mirea, L., Serrano, L., Sierra, P., Sabate, S., Hernando, D., Matute, P., Trashorras, M., Sune, M., Sarmiento, L., Hervias, A., Gonzalez, O. (Orland), Hermina, A., Perez, R.N., Orts, M., Fernandez-Garcia, R., Perez, D.S., Gil, I.S., Monedero, P., Hidalgo, F., Mbongo, C., Pont, A.R., Reyes, H.M., Bartolo, C.G., Galera, S.L., Valentijn, T, Stolker, R.J. (Robert), Tugrul, M., Demirel, E.E., Hough, M, Griffiths, K., Birch, D.G. (David ), Beardow, Z., Elliot, S., Thompson, J., Bowrey, S., Northey, M., Melson, H., Telford, R., Nadolski, M., Potter, A., Fuller, D., Rose, A., Varma, S., Simeson, K., Pettit, J., Smith, N, Martinson, V., Sleight, L., Naylor, C., Watt, P., Raymode, P., Dunk, N., Twohey, L., Hollos, L., Davies, S. (Simon), Gibson, A., Coleman, Z., Tamm, T., Joscak, J., Zsisku, L., Zuleika, M., Carvalho, P., Collyer, T., Ryan, J., Colling, K., Dharmarajah, S., Krishnan, A, Paddle, J., Fouracres, A., Arnell, K., Muhammad, K., Howell, S.J. (Simon), Hoeks, S.E. (Sanne), West, R.M. (Robert), Wheatcroft, T.B. (Tephen), Hoeft, A., Leva, B., Plichon, B., Damster, S., Momeni, M. (Mona), Watremez, C., Kahn, D., Dincq, A.S., Danila, A., Wittmann, M., Struck, R., Ruddel, T., Kessler, F., Rasche, S., Matsota, P., Hasani, A., Gudaityte, J., Karbonskiene, A., Ferreira, R., Carvalho, S., Tomescu, D., Martac, C., Grintescu, I., Mirea, L., Serrano, L., Sierra, P., Sabate, S., Hernando, D., Matute, P., Trashorras, M., Sune, M., Sarmiento, L., Hervias, A., Gonzalez, O. (Orland), Hermina, A., Perez, R.N., Orts, M., Fernandez-Garcia, R., Perez, D.S., Gil, I.S., Monedero, P., Hidalgo, F., Mbongo, C., Pont, A.R., Reyes, H.M., Bartolo, C.G., Galera, S.L., Valentijn, T, Stolker, R.J. (Robert), Tugrul, M., Demirel, E.E., Hough, M, Griffiths, K., Birch, D.G. (David ), Beardow, Z., Elliot, S., Thompson, J., Bowrey, S., Northey, M., Melson, H., Telford, R., Nadolski, M., Potter, A., Fuller, D., Rose, A., Varma, S., Simeson, K., Pettit, J., Smith, N, Martinson, V., Sleight, L., Naylor, C., Watt, P., Raymode, P., Dunk, N., Twohey, L., Hollos, L., Davies, S. (Simon), Gibson, A., Coleman, Z., Tamm, T., Joscak, J., Zsisku, L., Zuleika, M., Carvalho, P., Collyer, T., Ryan, J., Colling, K., Dharmarajah, S., Krishnan, A, Paddle, J., Fouracres, A., Arnell, K., and Muhammad, K.
- Abstract
Background: The perioperative management of antiplatelet therapy in noncardiac surgery patients who have undergone previous percutaneous coronary intervention (PCI) remains a dilemma. Continuing dual antiplatelet therapy (DAPT) may carry a risk of bleeding, while stopping antiplatelet therapy may increase the risk of perioperative major adverse cardiovascular events (MACE). Methods: Occurrence of Bleeding and Thrombosis during Antiplatelet Therapy In Non-Cardiac Surgery (OBTAIN) was an international prospective multicentre cohort study of perioperative antiplatelet treatment, MACE, and serious bleeding in noncardiac surgery. The incidences of MACE and bleeding were compared in patients receiving DAPT, monotherapy, and no antiplatelet therapy before surgery. Unadjusted risk ratios were calculated taking monotherapy as the baseline. The adjusted risks of bleeding and MACE were compared in patients receiving monotherapy and DAPT using propensity score matching. Results: A total of 917 patients were recruited and 847 were eligible for inclusion. Ninety-six patients received no antiplatelet therapy, 526 received monotherapy with aspirin, and 225 received DAPT. Thirty-two patients suffered MACE and 22 had bleeding. The unadjusted risk ratio for MACE in patients receiving DAPT compared with monotherapy was 1.9 (0.93e3.88), P¼0.08. There was no difference in MACE between no antiplatelet treatment and monotherapy 1.03 (0.31e 3.46), P¼0.96. Bleeding was more frequent with DAPT 6.55 (2.3e17.96) P¼0.0002. In a propensity matched analysis of 177 patients who received DAPT and 177 monotherapy patients, the risk ratio for MACE with DAPT was 1.83 (0.69e4.85), P¼0.32. The risk of bleeding was significantly greater in the DAPT group 4.00 (1.15e13.93), P¼0.031. Conclusions: OBTAIN showed an increased risk of bleeding with DAPT and found no evidence for protective effects of DAPT from perioperative MACE in patients who have undergone previous PCI.
- Published
- 2019
- Full Text
- View/download PDF
345. Applying the Aboveground-Belowground Interaction Concept in Agriculture: Spatio-Temporal Scales Matter
- Author
-
Veen, G.F., Wubs, E.R.J., Bardgett, Richard D., Barrios, Edmundo, Bradford, M.A., Carvalho, S., De Deyn, Gerlinde, De Vries, Franciska T., Giller, K.E., Kleijn, David, Landis, D.A., Rossing, W.A.H., Schrama, Maarten, Six, Johan, Struik, P.C., van Gils, Stijn, Wiskerke, J.S.C., van der Putten, W.H., Vet, L.E.M., Veen, G.F., Wubs, E.R.J., Bardgett, Richard D., Barrios, Edmundo, Bradford, M.A., Carvalho, S., De Deyn, Gerlinde, De Vries, Franciska T., Giller, K.E., Kleijn, David, Landis, D.A., Rossing, W.A.H., Schrama, Maarten, Six, Johan, Struik, P.C., van Gils, Stijn, Wiskerke, J.S.C., van der Putten, W.H., and Vet, L.E.M.
- Published
- 2019
346. Efficiency of transgene expression in bovine cells varies according to cell type and gene transfer method
- Author
-
Curcio, Alinne G, Bressan, Fabiana Fernandes, Carvalho, S., Quirino, Célia Raquel, Meirelles, Flávio Vieira, Burla-Dias, Ángelo J, Curcio, Alinne G, Bressan, Fabiana Fernandes, Carvalho, S., Quirino, Célia Raquel, Meirelles, Flávio Vieira, and Burla-Dias, Ángelo J
- Abstract
Background: Production of transgenic animals is still a low-efficiency biotechnology, and simple alternatives should be used to improve the rate of transgenic bovine production by nuclear transfer. One such alternative is selecting the appropriate donor cell type and transfection method. Objective: To investigate the effect of cell type (fetal or adult fibroblasts, and cumulus cells), and gene transfer method (lipofection and lentiviral transduction) on the incorporation, expression, and fluorescence intensity of transgene on bovine cells analyzed by flow cytometry. Methods: Fetal fibroblasts (FF), adult fibroblasts (AF), and cumulus cells (CC) were transfected using lipofection, or transduced using lentiviral particles produced with Green Fluorescent Protein (GFP) expressing plasmids, and analyzed by flow cytometry. Results: Lentiviral transduction resulted in higher transgene expression rates for all cell types (FF: 88.8 ± 0.98; AF: 91.6 ± 2.96; CC: 60.7% ± 14.7) compared to lipofection (FF: 17.8 ± 2.82; AF: 10.66 ± 0.65; CC: 3.9% ± 1.97). Cumulus cells showed lower transgene expression rates than the other cell types. Regarding fluorescence intensity, there was no significant difference between lipofection and lentiviral transduction; in both treatments, higher fluorescence intensity was obtained when adult cells were used instead of fetal cells. Conclusion: Gene transfer efficiency varies according to cell type, and gene transfer method, with lentiviral transduction achieving higher transgene expression rate, and adult fibroblasts showing better transgene expression., Resumo Antecedentes: A produção de animais transg ê nicos é uma biotecnologia que ainda apresenta baixa eficiência e alternativas simples devem ser usadas para o aumento da produção de bovinos transgênicos por transferência nuclear. Uma destas alternativas compreende a seleção do tipo apropriado de célula doadora de núcleo e do método de transferência gênica. Objetivo: Investigar a influ ê ncia do tipo celular (fibroblastos fetais ou adultos, e células do cumulus), e do método de transferência gênica (transfecção por lipofecção ou transdução lentiviral) na incorporação, expressão, e na intensidade de fluorescência do transgene em células bovinas analisadas por citometria de fluxo. Métodos: Fibroblastos fetais (FF), fibroblastos adultos (AF), e células do cumulus (CC) foram submetidas à lipofecção ou à transfecção lentiviral utilizando plasmídeos expressando a Proteína Fluorescente Verde - GFP). Resultados: A transdução lentiviral resultou em maiores taxas de expressão do transgene em todos os tipos celulares (FF: 88,8 ± 0,98; AF: 91,6 ± 2,96; CC: 60,7% ± 14.7) quando comparada com a lipofeccção (FF: 17,8 ± 2,82; AF: 10,66 ± 0,65; CC: 3,9% ± 1,97). As células do cumulus apresentaram menores taxas de expressão quando comparadas aos outros tipos celulares. Com relação à intensidade de fluorescência, não houve diferença significativa entre a lipofecção e a transdução lentiviral e em ambos os tratamentos as células adultas apresentaram maior intensidade de fluorescência do que as células fetais. Conclusão: A eficiência de transferência gênica varia de acordo com o tipo celular, e com o método de transferência gênica, sendo que a transdução lentiviral resultou em maiores taxas, e que os fibroblastos adultos mostraram melhor expressão do transgene., Resumen Antecedentes: La producción de animales transgénicos sigue siendo una biotecnología de baja eficiencia, y se deberían utilizar alternativas sencillas para mejorar la tasa de producción de bovinos transgénicos mediante transferencia nuclear. Una de estas alternativas es la selección del tipo mas apropiado de c é lula donante y m é todo de transferencia génica. Objetivo: Investigar el efecto del tipo celular (fibroblastos fetales o adultos, y celulas del cumulus), y el método de transferencia génica (lipofección y transducción lentiviral) en la incorporación, expresión génica, y la intensidad de fluorescencia del transgén en células bovinas analizadas por citometría de flujo. Métodos: Fibroblastos fetales (FF), fibroblastos adultos (AF), y células del cúmulo (CC) fueron transfectados a través de lipofección o transducidos utilizando partículas lentivirales producidas con plásmidos que expresan la proteína verde fluorescente (GFP). Resultados: La transducción lentiviral dio lugar a mayores tasas de expresión del transgen en todos los tipos de células (FF: 88,8 ± 0,98; AF: 91,6 ± 2,96, CC: 60,7% ± 14,7) en comparación con la lipofección (FF: 17,8 ± 2,82; AF: 10,66 ± 0,65; CC: 3,9% ± 1,97). Las células del cúmulus mostraron menores tasas de expresión del transgen que los otros tipos celulares. En cuanto a la intensidad de fluorescencia, no hubo diferencias significativas entre lipofección y transducción lentiviral; en ambos tratamientos, se obtuvo una mayor intensidad de fluorescencia cuando se usaron células adultas en lugar de células fetales. Conclusión: La eficiencia de la transferencia de genes varía según el tipo de célula y el método de transferencia génica, con la transducción lentiviral se logra una mayor tasa de transfección, y los fibroblastos adultos muestran una mejor expresión transgénica.
- Published
- 2019
347. Challenges and caveats of a multi-center retrospective radiomics study: An example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
- Author
-
Timmeren, J.-E., Carvalho, S., Leijenaar, R. T. H., Troost, E. G. C., Elmpt, W., Ruysscher, D., Muratet, J. P., Denis, F., Schimek-Jasch, T., Nestle, U., Jochems, A., Woodruff, H. C., Oberije, C., Lambin, P., Timmeren, J.-E., Carvalho, S., Leijenaar, R. T. H., Troost, E. G. C., Elmpt, W., Ruysscher, D., Muratet, J. P., Denis, F., Schimek-Jasch, T., Nestle, U., Jochems, A., Woodruff, H. C., Oberije, C., and Lambin, P.
- Abstract
Background Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/ CT) scan acquired during treatment. Methods The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called ‘cohort differences model’ approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. Results The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. Conclusion The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of co
- Published
- 2019
348. Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies
- Author
-
Maron, R., Schechter, B., Nataraj, N. B., Ghosh, S., Romaniello, D., Marrocco, Ilaria, Noronha, A., Carvalho, S., Yarden, Y., Sela, M., Marrocco I. (ORCID:0000-0002-8225-2177), Maron, R., Schechter, B., Nataraj, N. B., Ghosh, S., Romaniello, D., Marrocco, Ilaria, Noronha, A., Carvalho, S., Yarden, Y., Sela, M., and Marrocco I. (ORCID:0000-0002-8225-2177)
- Abstract
By year 2025 pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of cancer related death. However, other than improved chemotherapy and a small molecule inhibitor of the epidermal growth factor receptor (EGFR), no targeted drugs are currently available. Repurposing of approved drugs might offer a rapid solution. We employed an animal PDAC model, expressing a mutant and a wild type form of p53 and KRAS, respectively. Cetuximab, a clinically approved anti-EGFR monoclonal antibody (mAb) weakly inhibited PDAC xenografts, similar to trastuzumab, a mAb against HER2, a co-receptor of EGFR. Because the combination of cetuximab and trastuzumab only moderately enhanced the anti-tumor effects, we combined each with a home-made mAb to the same receptor and identified two cooperative pairs. The pair of trastuzumab and a murine anti-HER2 mAb better than the anti-EGFR pair inhibited PDAC xenografts, although HER2's abundance in our model is 15-fold lower than the level of EGFR. In vitro studies attribute cooperation to forced receptor endocytosis/degradation and inhibition of both DNA synthesis and cell migration. Taken together, our results identify cooperative pairs of anti-PDAC antibodies and highlight potential mechanisms of anti-tumor effects.
- Published
- 2019
349. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites
- Author
-
NASCIMENTO, I., SCHAER, R., LEMAIRE, D., FREIRE, S., PAULE, B., CARVALHO, S., MEYER, R., and SCHAER-BARBOSA, H.
- Published
- 2004
350. Evaluation of a recombinant enzyme immunoassay for syphilis screening in a blood bank routine
- Author
-
Dias, S, Lajchter, D, Silva, M, Lindoso, J, Amorim, L, and Carvalho, S
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.